Covered recipient · General Payments record
JENNIFER L BALSANO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$820.90
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $474.74 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $161.90 | 7 |
| MIMEDX Group, Inc. | $102.46 | 1 |
| Stryker Corporation | $79.19 | 1 |
| Evofem Biosciences, Inc. | $49.51 | 3 |
| Astellas Pharma US Inc | $31.46 | 2 |
| Teva Pharmaceuticals USA, Inc. | $20.27 | 1 |
| Lilly USA, LLC | $16.18 | 1 |
| Agile Therapeutics, Inc. | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $102.50 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477874 | CMS |
| ABBVIE INC. | $5.70 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477876 | CMS |
| ABBVIE INC. | $7.25 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477878 | CMS |
| ABBVIE INC. | $6.25 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477880 | CMS |
| ABBVIE INC. | $5.13 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477882 | CMS |
| ABBVIE INC. | $22.51 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477884 | CMS |
| ABBVIE INC. | $12.56 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106477886 | CMS |
| Agile Therapeutics, Inc. | $13.77 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154844923 | CMS |
| Astellas Pharma US Inc | $18.25 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139499652 | CMS |
| Astellas Pharma US Inc | $13.21 | 08/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139511987 | CMS |
| Evofem Biosciences, Inc. | $14.14 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091280503 | CMS |
| Evofem Biosciences, Inc. | $21.97 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091280507 | CMS |
| Evofem Biosciences, Inc. | $13.40 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091280499 | CMS |
| Lilly USA, LLC | $16.18 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135683563 | CMS |
| MIMEDX Group, Inc. | $102.46 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140272920 | CMS |
| Stryker Corporation | $79.19 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120026549 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.27 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151597478 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.